Key Highlights
● Nasdaq notified the company on August 20 of a further listing-rule deficiency.
● The company remains delinquent on its 2025 Form 10-K and first-quarter Form 10-Q.
● Nasdaq granted an extension to October 12, 2026.
● The delay stems from accounting for long-duration insurance contracts.
Atlantic American Corporation (NASDAQ:AAME), an Atlanta-based insurance holding company whose common stock trades on the Nasdaq Global Market under the ticker AAME, disclosed on 26 August 2026 that Nasdaq had notified it on 20 August of a further listing-rule deficiency. The notice cited Listing Rule 5250(c)(1), which requires listed companies to file periodic reports with the US Securities and Exchange Commission on time. The latest trigger was the unfiled Form 10-Q for the quarter ended 30 June 2026.
The company also remains delinquent on its Form 10-K for the year ended 31 December 2025 and its Form 10-Q for the quarter ended 31 March 2026. Nasdaq stated that the notice has no immediate effect on the listing or trading of the shares.
How the Delays Built Up
The sequence can be traced through the company's filings. A late-filing notice for the 2025 annual report was lodged on 1 April 2026, and Nasdaq issued its first deficiency notice on 21 April. A similar late-filing notice for the first-quarter report followed on 18 May, with a second Nasdaq notice dated 21 May. On 5 May the company also announced the resignation of its chief financial officer, J. Ross Franklin, effective 27 May 2026.
Nasdaq then granted an extension to 12 October 2026 after the company submitted a compliance plan, as disclosed on 15 July. On 17 August the company filed a further late-filing notice for the June quarter.
The Reason Given
The company said it needs more time to compile and analyse information required under Accounting Standards Update 2018-12, the US accounting rules for long-duration insurance contracts, and that its independent auditor also needs time to complete procedures. The filings did not set specific filing dates, saying only that the reports would be filed as promptly as practicable within the extension period.
Lenders and the October Deadline
The credit agreement matters too. Filings show that the company's revolving facility with Truist was amended in June and again on 5 August 2026 to extend the deadline for delivering financial information to 12 October 2026, the same date as the Nasdaq extension. That alignment suggests the company faces two pressure points at once, although the filings do not describe any default or waiver beyond those amendments.
The company had until 4 September to submit an updated plan to Nasdaq for the June quarter report. If Nasdaq accepts it, any extension for that report is limited to 12 October. If Nasdaq declines, the company may appeal to a Hearings Panel.
An Expired Deadline With an Unknown Outcome
Late reporting leaves shareholders and lenders without audited annual figures for 2025 and without current quarterly results, which makes the insurer harder to value. For historical context only, the second quarter of 2025 produced net income of $3.3 million on net insurance premiums of $50.1 million, as reported in August 2025. The delayed work concerns accounting for long-duration contracts, so comparability may change once new reports appear.
The stated deadline of 12 October 2026 has now passed. No filing, press release or Nasdaq announcement dated after 26 August was found, so it could not be confirmed whether the reports were filed or the deadline was extended further.
The October deadline is a disclosure event whose outcome is currently unknown.






Please wait processing your request...